Clinical Trial Update: Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating cardiac safety and efficacy of pegylated liposomal doxorubicin in early-stage breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: Fudan University | Conditions: Early Breast Cancer | Phase 3 | Status: UNKNOWN